Home » Topics » BioWorld Science

BioWorld Science
RSS

GlaxoSmithKline and ViiV Healthcare patent new compounds for HIV

Sep. 27, 2019

Immutep announces positive interim data from TACTI-002 phase II study

Sep. 27, 2019

Immunicum presents complete topline data from phase II MERECA study

Sep. 27, 2019

First patient dosed in phase IIb ICONA study of icosabutate

Sep. 27, 2019

FDA authorizes first-in-human clinical trial of AZD-0466

Sep. 27, 2019

TRPC4AP identified as gene biomarker candidate in thyroid dysgenesis

Sep. 27, 2019

FABP4 as a novel biochemical marker in diabetic ketoacidosis in children

Sep. 27, 2019

Dual CB1R/iNOS antagonist MRI-1867 ameliorates obesity-induced CKD in vivo

Sep. 27, 2019

BAL-101553 treatment associated with inhibition of CSLC-mediated tumor angiogenesis in vivo

Sep. 27, 2019

Study reports new insight into, target for Krabbe disease

Sep. 27, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...